Literature DB >> 15533659

An analytical perspective on favoured synthetic routes to the psychoactive tryptamines.

Simon D Brandt1, Sally Freeman, Peter McGagh, Norliza Abdul-Halim, John F Alder.   

Abstract

Many tryptamine derivatives are known to induce altered states of consciousness and are increasingly of interest in forensic and neurobiological studies. The analytical chemistry of certain synthetic routes to the tryptamines is discussed and likely side products and impurities identified, where literature reports are available. Recent examples from the authors' laboratory are presented to highlight future prospects and implications for analytical procedures. The aim of this review is to provide the analytical chemist with the foundation chemistry and some analytical targets to be able to undertake direct characterisation of products and intermediates. These might become available from interdiction of clandestine operations in a forensic environment or during the synthesis of the tryptamines for investigative neurobiological and clinical procedures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533659     DOI: 10.1016/j.jpba.2004.08.022

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2011-04-04       Impact factor: 3.922

Review 2.  Recreational use, analysis and toxicity of tryptamines.

Authors:  Roberta Tittarelli; Giulio Mannocchi; Flaminia Pantano; Francesco Saverio Romolo
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

3.  Stress-Induced Mucus Secretion and Its Composition by a Combination of Proteomics and Metabolomics of the Jellyfish Aurelia coerulea.

Authors:  Wenwen Liu; Fengfeng Mo; Guixian Jiang; Hongyu Liang; Chaoqun Ma; Tong Li; Lulu Zhang; Liyan Xiong; Gian Luigi Mariottini; Jing Zhang; Liang Xiao
Journal:  Mar Drugs       Date:  2018-09-18       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.